Epigenetics is defined as heritable changes that affect gene expression without altering the DNA sequence. Epigenetic regulation of gene expression is facilitated through different mechanisms such as DNA methylation, histone modifications and RNA-associated silencing by small non-coding RNAs. All these mechanisms are crucial for normal development, differentiation and tissue-specific gene expression. These three systems interact and stabilize one another and can initiate and sustain epigenetic silencing, thus determining heritable changes in gene expression. Histone acetylation regulates diverse cellular functions including inflammatory gene expression, DNA repair and cell proliferation. Transcriptional coactivators possess intrinsic histone acetyltransferase activity and this activity drives inflammatory gene expression. Eleven classical histone deacetylases (HDACs) act to regulate the expression of distinct subsets of inflammatory/immune genes. Thus, loss of HDAC activity or the presence of HDAC inhibitors can further enhance inflammatory gene expression by producing a gene-specific change in HAT activity. For example, HDAC2 expression and activity are reduced in lung macrophages, biopsy specimens, and blood cells from patients with severe asthma and smoking asthmatics, as well as in patients with chronic obstructive pulmonary disease (COPD). This may account, at least in part, for the enhanced inflammation and reduced steroid responsiveness seen in these patients. Other proteins, particularly transcription factors, are also acetylated and are targets for deacetylation by HDACs and sirtuins, a related family of 7 predominantly protein deacetylases. Thus the acetylation/deacetylation status of NF-κB and the glucocorticoid receptor can also affect the overall expression pattern of inflammatory genes and regulate the inflammatory response. Understanding and targeting specific enzymes involved in this process might lead to new therapeutic agents, particularly in situations in which current antiinflammatory therapies are suboptimal.
INTRODUCTION
Many lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease and acute respiratory distress syndrome, involve inflammation, with the coordinate expression of multiple inflammatory genes in the lungs. Post-translational modifications of histones play an important role in epigenetic regulation of gene expression, and thus have critical effects on environment-mediated chronic lung diseases such as COPD and asthma (4, 5) .
Since histones are post-translationally modified during disease progression, the identification of these patterns as well as the altered activity of the enzymes that 'write' and 'erase' these marks are important mechanisms for the understanding of human diseases. The most intensively studied modifications are histone acetylation and methylation which through the action of specific enzymes form marks that allow 'readers' of these marks to remodel
chromatin producing the open chromatin structure associated with active gene transcription or a closed repressive chromatin state linked to a lack of active transcription (6). For example, an acetylated lysine residue forms a bromodomain that is read by many enzymes and transcription regulating factors (7) (Fig. 1) . mono-, di-and tri-methylated lysine. As a result this will not be discussed here but the reader is directed to an excellent review (18) . The role of small non-coding RNAs in the epigenetic control of inflammation is becoming increasingly apparent such as the differential expression of miR38-5p and miR146 in severe asthma (19) . A review of the roles of miRNAs in airways disease is not discussed here but is discussed elsewhere (20, 21) .
Chromatin modification and inflammatory gene expression
Gene expression in all tissues including the lung is regulated, at least in part, through coordinated changes in the pattern of histone post translational modifications (22) (23) (24) (25) (26) . The specific role of histone acetylation via the actions of histone acetylases (HAT) and histone deacetylases (HDAC) has been extensively described (22) (23) (24) (25) (26) . In a simplistic form increased histone acetylation is associated with increased inflammatory gene expression. Increased
HAT activity and decreased HDAC activity have been reported in asthma along with reduced HDAC activity in COPD. In both cases this is linked to the altered inflammatory response seen in these diseases (27) . (36) (Fig. 4) . and apoptosis (40, 41) and are therefore implicated in many types of cancer (42, 43) (Fig. 3) . However, the actions of HDAC inhibitors used in cancer therapy probably relates to their effects on non-histone proteins (44) .
Role and function of epigenetic modifications in pathogenesis of lung diseases
A) Lung cancer: Changes in DNA methylation are also In COPD patients' peripheral lung and airway biopsy specimens, and alveolar macrophages, there is an increase in the acetylation of histones associated with the promoter region of inflammatory genes, such as CXCL8, that are regulated by NF-κB and the degree of acetylation increases with disease severity (27) .
This increased acetylation of inflammatory genes is not due to any global increase in histone acetyltransferase activity in the lungs or macrophages but a reduction in HDAC activity in alveolar macrophages of cigarette smokers compared to nonsmokers, and this is correlated with increased expression of inflammatory genes in these cells (58, 59) . There is also a reduction in total HDAC activity in peripheral lung, bronchial biopsy specimens and alveolar macrophages from COPD patients and this is correlated with disease severity and with increased gene expression of CXCL8 (27) .
There is a selective reduction in the expression of HDAC-2, with lesser reductions in HDAC-3, -5 and -8 and an increase in HDAC-4 and -6 (27) . 
